Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|1|1|93-108

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.1, Iss.1, 2005-01, pp. : 93-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor

By Gerin Fethullah   Baloglu Orkun   Morgan Jeffrey   Kesari Santosh  

Journal of Neuro-Oncology, Vol. 82, Iss. 2, 2007-04 ,pp. : 227-228

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Advanced Gastrointestinal Stromal Tumor: a Marriage of Targeted Therapy and Surgery?

By DeMatteo Ronald  

Annals of Surgical Oncology, Vol. 14, Iss. 1, 2007-01 ,pp. : 1-2

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors

By Tonyali Onder   Coskun Ugur   Yildiz Ramazan   Karakan Tarkan   Demirci Umut   Akyurek Nalan   Benekli Mustafa   Buyukberber Suleyman  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 768-773

Humana Press, Inc

Access to resources Recommend Favorite

Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 88-99

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Midkine Correlates with Tumor Progression and Imatinib Response in Gastrointestinal Stromal Tumors

By Rawnaq Tamina  

Annals of Surgical Oncology, Vol. 18, Iss. 2, 2011-02 ,pp. : 559-565

Springer Publishing Company

Access to resources Recommend Favorite